Current Liabilities

Accrued Royalties (Current)

Moderna Accrued Royalties (Current) increased by 3019.4% to $967.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19240.0%, from $5.00M to $967.00M.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2020
Last reportedQ1 2026May 1, 2026

How to read this metric

An increase generally correlates with higher sales of licensed products, reflecting successful commercialization efforts.

Detailed definition

The liability representing royalty payments that have been earned by third parties based on product sales but have not y...

Peer comparison

Specific to companies with licensed technology or intellectual property, common in the biotech sector.

Metric ID: accrued_royalties_current

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$146.00M$168.00M$241.00M$207.00M$158.00M$106.00M$203.00M$86.00M$12.00M$78.00M$122.00M$8.00M$10.00M$92.00M$46.00M$5.00M$6.00M$42.00M$31.00M$967.00M
QoQ Change+15.1%+43.5%-14.1%-23.7%-32.9%+91.5%-57.6%-86.0%+550.0%+56.4%-93.4%+25.0%+820.0%-50.0%-89.1%+20.0%+600.0%-26.2%>999%
YoY Change+8.2%-36.9%-15.8%-58.5%-92.4%-26.4%-39.9%-90.7%-16.7%+17.9%-62.3%-37.5%-40.0%-54.3%-32.6%>999%
Range$5.00M$967.00M
CAGR+48.9%
Avg YoY Growth>999%
Median YoY Growth-37.2%

Accrued Royalties (Current) at Other Companies

Frequently Asked Questions

What is Moderna's accrued royalties (current)?
Moderna (MRNA) reported accrued royalties (current) of $967.00M in Q1 2026.
How has Moderna's accrued royalties (current) changed year-over-year?
Moderna's accrued royalties (current) increased by 19240.0% year-over-year, from $5.00M to $967.00M.
What does accrued royalties (current) mean?
Royalties owed to partners or licensors that are due to be paid soon.